![]() |
JOURNAL TOOLS |
Publishing options |
eTOC |
To subscribe |
Recommend to your librarian |
ARTICLE TOOLS |
Publication history |
Reprints |
Permissions |
Cite this article as |
Share |


YOUR ACCOUNT
YOUR ORDERS
SHOPPING BASKET
Items: 0
Total amount: € 0,00
HOW TO ORDER
YOUR SUBSCRIPTIONS
YOUR ARTICLES
YOUR EBOOKS
COUPON
ACCESSIBILITY
CASE REPORT
Journal of Radiological Review 2021 March;8(1):47-50
DOI: 10.23736/S2723-9284.20.00055-X
Copyright © 2020 EDIZIONI MINERVA MEDICA
language: English
Embolization of hemorrhagic lymphangioleiomyomatotis-associated angiomyolipoma
Gianvito CANDITA 1 ✉, Alessandro MARCUCCI 1, Chiara BOCCACCIO 1, Ilaria CARAMELLA 2
1 University of Pisa, Pisa, Italy; 2 University of Bologna, Bologna, Italy
The treatment of renal angiomyolipoma (AML) in female patients with a concurrent diagnosis of lymphangioleiomyomatosis (LAM) is a topical challenge in medicine. Renal AMLs occurring in patients with LAM are usually multiple, bilateral, fast-growing and present a high risk of life-threatening bleeding, whereby a nephron-sparing procedure is necessary in order to treat the lesion and to prevent the comparison of renal failure due to the treatment. The advent of selective artery embolization (SAE) represents a minimally invasive, effective and safe alternative to surgery or medical treatment.
KEY WORDS: Angiomyolipoma; Embolization, therapeutic; Lymphangioleiomyomatosis